Cargando…
Comparative efficacy and safety of JAK inhibitors and leflunomide in rheumatoid arthritis: A protocol for systematic review and meta-analysis
Rheumatoid arthritis is the most prevalent systemic autoimmune disease among the rheumatic inflammatory musculoskeletal diseases. Currently, there is no reliable evidence regarding the comparisons of anti-rheumatic effects between leflunomide and Janus kinase inhibitors. We performed a protocol for...
Autores principales: | Zhang, Xiaogang, Zhang, Mingming, Wang, Zhiqiang, Liu, Yanqing, Feng, Xing, Yang, Liu, Wang, Yajing, Liu, Juan, Zhao, Dongbao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750582/ https://www.ncbi.nlm.nih.gov/pubmed/36626515 http://dx.doi.org/10.1097/MD.0000000000032154 |
Ejemplares similares
-
Clinical efficacy and safety of methotrexate compared with leflunomide in the treatment of rheumatoid arthritis: A protocol for systematic review and meta-analysis
por: Qi, Weiyu, et al.
Publicado: (2021) -
Hepatitis E infection in a patient with rheumatoid arthritis treated with leflunomide: A case report with emphasis on geoepidemiology
por: Carubbi, Francesco, et al.
Publicado: (2019) -
Diffuse alveolar damage in a patient with rheumatoid arthritis under prolonged leflunomide treatment: A Case Report and Literature Review
por: Keng, Li-Ta, et al.
Publicado: (2016) -
Real-world comparative effectiveness of bDMARDs and JAK inhibitors in elderly patients with rheumatoid arthritis
por: Temmoku, Jumpei, et al.
Publicado: (2022) -
A case of chronic eosinophilic pneumonia associated with rheumatoid arthritis in glucocorticoid-free remission with JAK inhibitor: A case report
por: Yamane, Takashi, et al.
Publicado: (2023)